calpain-inhibitor-iii and Nervous-System-Diseases

calpain-inhibitor-iii has been researched along with Nervous-System-Diseases* in 1 studies

Other Studies

1 other study(ies) available for calpain-inhibitor-iii and Nervous-System-Diseases

ArticleYear
Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor.
    Brain research, 1993, Apr-02, Volume: 607, Issue:1-2

    The effects of a membrane-permeable inhibitor of calpain, Cbz-Val-Phe-H, were examined in an in vitro model of neurotoxicity. Cerebellar slices from young rats were treated with the glutamate receptor agonist, amino-3-hydroxy-5-methyl-4-isoazole propionic acid (AMPA), and cytotoxicity was quantified using conventional histological techniques. Slices treated with AMPA exhibited damage to 83.0% of cerebellar Purkinje cells. In contrast, only 23.6% of Purkinje cells were damaged in slices treated with Cbz-Val-Phe-H and AMPA. These findings indicate that calcium-activated proteolysis is a critical event in AMPA-induced toxicity, and provide evidence that calpain inhibitors are capable of attenuating this form of excitotoxic damage in the central nervous system.

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acid Sequence; Animals; Calpain; Cerebellum; Dipeptides; Female; Ibotenic Acid; Molecular Sequence Data; Nervous System Diseases; Pregnancy; Purkinje Cells; Rats; Rats, Sprague-Dawley

1993